Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · IEX Real-Time Price · USD
58.28
-0.67 (-1.14%)
At close: Apr 19, 2024, 4:00 PM
58.29
+0.01 (0.02%)
After-hours: Apr 19, 2024, 4:29 PM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $2.10 billion as of April 19, 2024. Its market cap has increased by 85.30% in one year.
Market Cap
2.10B
Enterprise Value
1.78B
1-Year Change
85.30%
Ranking
Category
Stock Price
$58.28
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $365.20M to $2.10B, an increase of 474.22%. That is a compound annual growth rate of 54.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 2.10B | -1.14% |
Apr 18, 2024 | 2.12B | -0.54% |
Apr 17, 2024 | 2.13B | 2.19% |
Apr 16, 2024 | 2.09B | 0.55% |
Apr 15, 2024 | 2.08B | -1.58% |
Apr 12, 2024 | 2.11B | -5.32% |
Apr 11, 2024 | 2.23B | 1.76% |
Apr 10, 2024 | 2.19B | -4.67% |
Apr 9, 2024 | 2.30B | 0.99% |
Apr 8, 2024 | 2.27B | 0.84% |
Apr 5, 2024 | 2.25B | 1.54% |
Apr 4, 2024 | 2.22B | -3.55% |
Apr 3, 2024 | 2.30B | -0.06% |
Apr 2, 2024 | 2.30B | -4.29% |
Apr 1, 2024 | 2.41B | 1.05% |
Mar 28, 2024 | 2.38B | 2.38% |
Mar 27, 2024 | 2.33B | -2.19% |
Mar 26, 2024 | 2.38B | -0.23% |
Mar 25, 2024 | 2.38B | 0.59% |
Mar 22, 2024 | 2.37B | -4.56% |
Mar 21, 2024 | 2.48B | 3.21% |
Mar 20, 2024 | 2.41B | 4.16% |
Mar 19, 2024 | 2.31B | 0.53% |
Mar 18, 2024 | 2.30B | -5.18% |
Mar 15, 2024 | 2.42B | 3.88% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
TG Therapeutics | 2.16B |
Kymera Therapeutics | 2.15B |
AMN Healthcare Services | 2.13B |
Rocket Pharmaceuticals | 2.13B |
Vericel | 2.12B |
Privia Health Group | 2.11B |
Intellia Therapeutics | 2.05B |
Guardant Health | 2.03B |